Abstract
The expansion of the antifungal armamentarium and the implementation of imaging techniques and new nonculture-based fungal diagnostics (NCBFDs) have improved the survival of patients with invasive asper-gillosis (IA). However, mortality rates still remain high, possibly influenced by several pitfalls, affecting NCBFDs and reducing the window of opportunity for earlier treatment. A large body of in vitro and in vivo studies has demonstrated that several fungal proteic components are strongly immunogenic, and both the adaptive immunity and the innate branch are heavily involved in the recognition and clearance of fungal pathogens, resulting, on occasion, in a useful tool for the treatment of IA. By evaluating these studies, this review considers the possibility of exploiting either components of the innate or adaptive immunity to support the rapid and early diagnosis of IA.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Upton A, Kirby KA, Carpenter P, et al.: Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007, 44:531–540.
Pagano L, Caira M, Nosari A, et al.: Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality SEIFEM-C report. Clin Infect Dis 2007, 44:1524–1525.
Walsh TJ, Anaissie EJ, Denning DW, et al.: Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008, 46:327–360.
Cornely OA, Maertens J, Bresnik M, et al.: Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007, 44:1289–1297.
Viscoli C, Herbrecht R, Akan H, et al.: Caspofungin as first-line therapy of invasive aspergillosis in haematological patients: a study of the EORTC infectious diseases group [abstract #O-43]. 3rd Trends in Medical Mycology. Turin, Italy; October 28–31, 2007.
Maertens J, Klont R, Masson C, et al.: Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis 2007, 44:1329–1336.
Senn L, Robinson JO, Schmidt S, et al.: 1,3-beta-D-glucan antigenemia for the early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008, 46:878–885.
Donnely JP: Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a way to go. Clin Infect Dis 2006, 42:487–489.
Leeflang MM, Debets-Ossenkopp YJ, Visser CE, et al.: Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev 2008, 4:CD007394.
Obayashi T, Negishi K, Suzuki T, et al.: Reappraisal of the serum (1-3)-beta-D-glucan assay for the diagnosis of invasive fungal infections: a study based on autopsy cases from 6 years. Clin Infect Dis 2008, 46:1864–1870.
De Pauw B, Walsh TJ, Donnelly PJ, et al.: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813–1821.
Mengoli C, Cruciani M, Barnes RA, et al.: Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009, 9:89–96.
Slobbe L, Polinder S, Doorduijn JK, et al.: Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study. Clin Infect Dis 2008, 47:1507–1512.
Cenci E, Perito S, Enssle KH, et al.: Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immunol 1997, 65:564–570.
Del Sero G, Mencacci A, Cenci E, et al.: Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect 1999, 1:1169–1180.
Romani L: Immunity to fungal infections. Nat Rev Immunol 2004, 4:1–13.
Garlanda C, Hirsch E, Bozza S, et al.: Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002, 420:182–186.
Rivera A, Collins N, Stephan MT, et al.: Aberrant tissue localization of fungus-specific CD4+ T cells in IL-10-deficient mice. J Immunol 2009, 183:631–641.
Cenci E, Mencacci A, Bacci A, et al.: T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 2000, 165:381–388.
Tao J, Segal BH, Eppolito C, et al.: Aspergillus fumigatus extract differentially regulates antigen-specific CD4+ and CD8+ T cell responses to promote host immunity. J Leukocyte Biol 2006, 80:1–9.
Yamada A, Kataoka T, Nagai K: The fungal metabolite gliotoxin: immunosuppressive activity on CTL-mediated cytotoxicity. Immunol Lett 2000, 71:27–32.
Romani L, Zelante T, De Luca A, et al.: IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 2008, 180:5157–5162.
Holding KJ, Dworkin MS, Wan PC, et al.: Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Clin Infect Dis 2000, 31:1253–1257.
Anaissie EJ: A bad bug takes on a new role as a cause of ventilator-associated pneumonia. Am J Respir Crit Care Med 2008, 177:1–2.
Nivoix Y, Velten M, Letscher-Bru V, et al.: Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008, 47:1176–1184.
Meesserman W, Lagrou K, Maertens J, et al.: Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007, 45:205–216.
Roilides E, Dimitriadou A, Kadiltsoglou I, et al.: IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol 1997, 158:322–329.
Roilides E, Katsifa H, Tsaparidou S, et al.: Interleukin-10 suppresses phagocytic and antihyphal activities of human neutrophils. Cytokine 2000, 12:379–387.
Roilides E, Sein T, Roden M, et al.: Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis. J Infect Dis 2001, 183:518–520.
Hebart H, Bollinger C, Fisch P, et al.: Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood 2002, 100:4521–4528.
Perruccio K, Tosti A, Burchielli E, et al.: Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 2005, 106:4397–4406.
Beck O, Topp MS, Koehl U, et al.: Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood 2006, 107:2562–2569.
Beck O, Koehl U, Tramsen L, et al.: Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood. J Immunol Methods 2008, 335:41–45.
Tramsen L, Koehl U, Tonn T, et al.: Clinician scale generation of human anti-Aspergillus T cells for adoptive immunotherapy. Bone Marrow Transplant 2009, 43:13–19.
Zhu F, Ramadan G, Davies B, et al.: Stimulation by means of dendritic cells followed by Epstein-Barr virus transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses. Clin Exp Immunol 2007, 151:284–296.
Sester M, Sester U, Gartner B, et al.: Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 2001, 71:1287–1294.
Widmann T, Sester U, Gartner BC, et al.: Levels of CMV specific T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation. Plos ONE 2008, 11:e3634.
Smets F, Latinne D, Bazin H, et al.: Ratio between Epstein-Barr viral load and anti- Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 2002, 73:1603–1610.
Barozzi P, Bonini C, Potenza L, et al.: Changes in the immune responses against human herpesvirus-8 in the disease course of post-transplant Kaposi sarcoma. Transplantation 2008, 44:738–744.
Barozzi P, Potenza L, Riva G, et al.: Changes in T cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi’s sarcoma in a patient with undifferentiated arthritis. Semin Arthritis Rheum 2008 Jul 16 (Epub ahead of print).
Comoli P, Hirsch HH, Ginevri F: Cellular immune responses to BK virus. Curr Opin Organ Transplant 2008, 13:569–574.
Lalvani A: Diagnosing tuberculosis infection in the 21st century. New tools to tackle an old enemy. Chest 2007, 131:1898–1906.
Ferrara G, Losi M, D’Amico R, et al.: Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006, 367:1328–1334.
al-Ramadi BK, Ellis M, Pasqualini F, Mantovani A: Selective induction of pentraxin 3, a soluble innate immune pattern recognition receptor, in infectious episodes in patients with haematological malignancy. Clin Immunol 2004, 112:221–224.
Biagi E, Col M, Migliavacca M, et al.: PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromise pediatric patients. J Pediatr Hematol Oncol 2008, 30:881–885.
Potenza L, Barozzi P, Vallerini D, et al.: Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates. Leukemia 2007, 21:578–581.
Potenza L, Barozzi P, Rossi G, et al.: Assessment of Aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis. Clin Vaccine Immunol 2008, 15:1625–1628.
Forghieri F, Rossi G, Potenza L, et al.: Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. Am J Hematol 2009 Apr 16 (Epub ahead of print).
Maertens J, Theunissen K, Verhoef G, et al.: Galactomannan and computed tomography-based pre-emptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005, 41:1242–1250.
Cordonnier C, Pautas C, Maury S, et al.: Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized controlled trial. Clin Infect Dis 2009, 48:1042–1051.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Potenza, L., Barozzi, P., Vallerini, D. et al. Diagnosis of aspergillosis: Role of proteomics. Curr Fungal Infect Rep 3, 216–222 (2009). https://doi.org/10.1007/s12281-009-0030-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12281-009-0030-x